Company:  PROTHENA CORP PLC (PRTA)
Form Type:  4
Filing Date:  5/19/2017 
CIK:  0001559053 
Address:  ADELPHI PLAZA
UPPER GEORGE'S STREET
 
City, State, Zip:  DUN LAOGHAIRE, CO. DUBLIN,  A96 T927 
Telephone:  011-353-1-236-2500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$14.62  
Change: 
-0.24 (-1.62%)  
Trade Time: 
May 25  
Market Cap: 
$582.20M
Trade PRTA now with 

© 2018  
Description of Business
Prothena Corporation plc ("Prothena" or the "Company") is a global, late-stage clinical biotechnology company establishing fully-integrated research, development and commercial capabilities and focused on advancing new therapies in the neuroscience and orphan disease categories. Fueled by its deep scientific understanding built over decades of research in protein misfolding, Prothena seeks to fundamentally change the course of grave or currently untreatable diseases associated with this biology. Our pipeline of antibody-based product candidates targets a number of potential indications including AL amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002/RG7935) and ATTR amyloidosis (PRX004). The Company continues to advance additional discovery programs where our deep scientific understanding of disease pathology can be leveraged.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES